Phase I trial, HS-25-802
This is an early-stage research study, often called a Phase I trial, named HS-25-802. It's looking for healthy volunteers between 18 and 55 years old. At the moment, the full details of what exactly will happen in this study are not publicly available. This is because the Health Research Authority (who oversees health research in the UK) has given permission for the information to be released later. All the specific details about the study will be added to the official records within 30 months after the study has been completed. This is a common practice in early research to protect confidential information until the appropriate time.
At a glance
What is this study about?
This research study, known as Phase I trial HS-25-802, is an early step in testing new treatments or interventions. Phase I trials are typically carried out in a small group of healthy volunteers to make sure any new treatment is safe and to understand how it works in the body.
The specific details about what this study involves, such as what treatments or procedures are being tested, are not available right now. The Health Research Authority (HRA), which is an organisation that looks after the interests of patients in health research, has agreed to keep these details private for now. While this might seem unusual, it's a standard process in medical research, especially in early stages, to protect confidential information.
All the information will eventually be made public. The full details will be added to the study's official record within 30 months after the study has finished. This means that while you can't see all the specifics volunteered for this study right now, they will become available for everyone to view in the future, ensuring transparency once the time is right.
Key takeaways
- This is an early-stage (Phase I) study testing something new.
- It's recruiting healthy volunteers aged 18 to 55.
- Full study details are currently withheld by the Health Research Authority but will be released later.
- Your health and safety would be closely monitored if you participated.
- Participation would mean contributing to future medical knowledge.
- You have the right to withdraw at any time.
Who may be eligible?
This study is looking for healthy adults. To be considered, you must be a healthy individual. Only people within a specific age range can take part.
Specifically, you need to be at least 18 years old but no older than 55 years old. This age range is important because treatments can affect people of different ages in different ways, and early studies often focus on particular age groups.
Both men and women are welcome to participate in this study, as long as they meet the age and healthy volunteer criteria. More detailed information, including any reasons why someone might not be able to join (called exclusion criteria), will be made available when the full study details are published.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you between 18 and 55 years old?
- Do you consider yourself to be a healthy person?
- Are you comfortable with details of the study not being fully public yet?
- Are you available for potential multiple visits and assessments?
What does participation involve?
As the full details of this study are currently not public, we cannot provide specific information about what taking part would involve. However, in typical Phase I trials for healthy volunteers, participation might include:
* **Screening Visits:** These are initial appointments to check your health and make sure you meet all the study requirements. This could involve physical exams, blood tests, and other medical checks. * **Treatment Visits:** These are the appointments where you would receive the study intervention (e.g., a new medicine). This could be a single visit or multiple visits over a period of time. You might have your vital signs monitored closely during these times. * **Assessments:** During and after receiving the intervention, you would likely have various tests and evaluations to see how your body reacts. This might include more blood tests, urine samples, or other investigations. * **Follow-up:** After the main part of the study, there might be follow-up appointments to ensure your health is stable and to check for any long-term effects.
The total duration of your participation would depend on the study design, which will be revealed later. Throughout the study, medical staff would be monitoring your health closely.
Potential risks and benefits
Locations (1)
- Fortrea Clinical Research UnitUnverifiedLeeds, England
Common questions
What is a 'Phase I' trial?
A Phase I trial is one of the earliest stages of testing a new treatment or medicine in humans. It mostly focuses on checking if it's safe and how the body handles it, usually in a small group of healthy volunteers.
Why aren't the full details of the study available now?
The Health Research Authority, a UK body, has allowed the study details to be kept private for now. This is a normal practice in early research to protect confidential information until the study is complete, or further along.
When will all the study details be made public?
All the specific details about the study will be added to the official records within 30 months after the study has officially finished.
Who can take part in this study?
This study is looking for healthy volunteers who are between 18 and 55 years old. Both men and women can participate.
Will I be compensated for taking part?
It's common for healthy volunteers in early-stage trials to receive some payment for their time and travel, but you would need to ask the study team for specific details once they become available.
How to find out more
VP Clinical Development
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.